Curated Grant Opportunities

Updated on 03/31/2021

Search by Type of Grant Opportunity or Keyword. Click Apply to Submit.*

Proposal Due: 7/1/2021
Sponsor: University of Rochester, Clinical & Translational Science Institute
Up to $50,000 total costs for one year

UNYTE Translational Research Network Grants The University of Rochester Clinical and Translational Science Institute (UR CTSI) is now accepting applications for Pilot Studies Program – UNYTE Category, with a potential start date of July 1, 2021. The UR CTSI Pilot Studies program offers awards of up to $50,000 for a period of one year to stimulate new inter-institutional research collaborations. Proposals must involve a new or expanded collaboration among a University of Rochester faculty member and one or more co-principal investigators from at least one of the participating UNYTE institutions. Proposals should involve an innovative, team-based health research project that reflects the particular strengths of UNYTE members and their institutions. Information about UNYTE member institutions can be found on the UNYTE web page.


Proposal Due: 5/24/2021
Sponsor: U.S. Department of Health and Human Services
$3.5 million total costs for up to 5 years

2021 NIAID DMID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2021-1 Introduction: The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. This Broad Agency Announcement is soliciting proposals that possess the research and development (R) expertise necessary for successfully carrying out research toward meeting the program objectives of the Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH. The Research Areas included in this NIAID DMID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2021-1, as well as the projected amounts of available funding, are discussed below.


Proposal Due: 5/24/2021
Sponsor: U.S. Department of Health and Human Services
$3.5 million total costs for up to 5 years

2021 NIAID DMID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2021-1 Introduction: The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. This Broad Agency Announcement is soliciting proposals that possess the research and development (R) expertise necessary for successfully carrying out research toward meeting the program objectives of the Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH. The Research Areas included in this NIAID DMID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2021-1, as well as the projected amounts of available funding, are discussed below.


Proposal Due: 5/24/2021
Sponsor: U.S. Department of Health and Human Services
$4 million total costs for up to 5 years

2021 NIAID DMID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2021-1 Introduction: The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. This Broad Agency Announcement is soliciting proposals that possess the research and development (R) expertise necessary for successfully carrying out research toward meeting the program objectives of the Division of Microbiology and Infectious Diseases (DMID), NIAID, NIH. The Research Areas included in this NIAID DMID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2021-1, as well as the projected amounts of available funding, are discussed below.


Proposal Due: 2021-06-05 2021-10-05 2022-02-05
Sponsor: U.S. Department of Health and Human Services
$499,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-21-166 Purpose The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes. This FOA specifies a partnership structure that is expected to help bridge gaps in knowledge and experience by engaging the strengths of academic, industrial, and other investigators.


Proposal Due: 2021-06-05 2021-10-05 2022-02-05
Sponsor: U.S. Department of Health and Human Services
$499,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-21-206 Purpose The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes. This FOA specifies a partnership structure that is expected to help bridge gaps in knowledge and experience by engaging the strengths of academic, industrial, and other investigators.


Proposal Due: 4/1/2021
Sponsor: American Cancer Society
$120,000 total costs per year for 3 years

Institutional Research Grants are block grants averaging $120,000 per year for 3 years given to institutions as ""seed money"" for the initiation of projects by promising junior investigators.. DESCRIPTION OF INSTITUTIONAL RESEARCH GRANTS An Institutional Research Grant (IRG) is a block award to an institution that enables it to give small grants to beginning investigators who do not have national peer-reviewed research grant support. The intent is to support these junior faculty in initiating cancer research projects so they can obtain preliminary results that will enable them to compete successfully for national research grants.


Proposal Due: 2021-11-08 2021-07-08
Sponsor: NIH
$500,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-19-251 Purpose The overall objective of this Funding Opportunity Announcement (FOA) is to support innovative research on adducts to cellular macromolecules as indicators of exposures to endogenous and exogenous cancer risk factors relevant to exposures in human populations. The priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. The ultimate goal is to discover and characterize the utility of adductomic-based exposure indicators for cancer detection, cancer prevention, and/or assessing cancer risks. These projects should explore the basic aspects of adducts/adductomics that may have a potential utility in cancer detection, cancer prevention, and/or assessing cancer risks. The projects must be relevant to adducts in humans and human populations but may be conducted using various model systems (e.g., cultured cells, animals, etc.).


Proposal Due: 9/27/2021
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-19-299 The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In order to accomplish this goal, NRSA training programs are designed to train individuals to conduct research and to prepare for research careers. More information about NRSA programs may be found at the Ruth L. Kirschstein National Research Service Award (NRSA) website.


Proposal Due: 7/31/2023
Sponsor: U.S. Department of Defense
75,000 per year for 2 years

Funding Opportunity Number: W81XWH-18-S-SOC1 This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 2358. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016 and in DoD Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge.


Proposal Due: 4/29/2021
Sponsor: U.S. Department of Defense
$200,000 total direct costs for 2 years

Funding Opportunity Number: W81XWH-21-PRMRP-DA The intent of the PRMRP Discovery Award is to support innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported by this award are expected to lay the groundwork for future DOD FY21 Peer Reviewed Medical Discovery Award 5 avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design. Innovation is the most important review criterion. Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that represents an incremental advancement on previously published work is not considered innovative.


Proposal Due: 5/11/2021
Sponsor: U.S. Department of Health and Human Services
$1 million direct costs per year for 5 years

Funding Opportunity Number: RFA-AR-22-001 Recommended length: 1-5 pages. Present the purpose of the funding opportunity in paragraph form, addressing all of the items below. Please keep in mind that readers will appreciate clarity and brevity. The following headers may be useful in preparing this section: Purpose/Research objectives (describe the nature and need of the research opportunity) Specific Areas of Research Interest (include examples of research topics. In such cases, add a statement indicating that appropriate topics ""include but are not limited to those listed below."" This section may also address scientific knowledge to be achieved through research supported by the special program and types of research and experimental approaches that are being sought to achieve the objectives. Literature citations from non-governmental sources should not be used except according to the diversity guidance.


Proposal Due: 5/10/2021
Sponsor: Gordon and Betty Moore Foundation
$500,000 total costs for 18 months

1. Project Description a) Purpose The purpose of this funding opportunity is to provide assistance in the form of grants for the development of innovative clinical quality measures (defined in Appendix A) that promote excellence in diagnosis of three categories of disease - acute vascular events, infections and cancer. b) Background The Diagnostic Excellence Initiative In November 2018, the Moore Foundation announced its Diagnostic Excellence Initiative with a focus on diagnostic performance improvement. The initiative aims to reduce harm from erroneous or delayed diagnoses, reduce costs and redundancy in the diagnostic process, improve health outcomes and save lives. The initiative's first area of focus is to develop and validate new measures for diagnostic performance. Examples of our first two cohorts of grants for diagnostic clinical quality measures are now available for review. Starting with measure development is important - currently, U.S.


Proposal Due: 9/20/2021
Sponsor: National Science Foundation
$175,000 total costs for a period of 24 months

Funding Opportunity Number: NSF 20-593 The NSF Directorate for Computer and Information Science and Engineering (CISE) seeks to award grants intended to support research independence among early-career academicians who specifically lack access to adequate organizational or other resources. It is expected that funds obtained through this program will be used to support untenured faculty or research scientists (or equivalent) in their first three years in a primary academic position after the PhD, but not more than five years after completion of their PhD. Applicants for this program may not yet have received any other grants or contracts in the PI role from any department, agency, or institution of the federal government, including from the CAREER program or any other program, post-PhD, regardless of the size of the grant or contract, with certain exceptions as noted below.


Proposal Due: 6/11/2021
Sponsor: U.S. Department of Defense
Not limited

Funding Opportunity Number: HR001120S0048 I.Funding Opportunity Description This Broad Agency Announcement (BAA) constitutes as a public notice of a competitive funding opportunity as described in Federal Acquisition Regulation (FAR) 6.102(d)(2) and 35.016 as well as 2 C.F.R. 200.203. Any resultant negotiations and/or awards will follow all laws and regulations applicable to the specific award instrument(s) available under this BAA, e.g., FAR 15.4 for procurement contracts. A. Introduction The mission of the Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is to identify and create the next generation of scientific discovery by pursuing high-risk, high-payoff research initiatives across a broad spectrum of science and engineering disciplines and transforming these initiatives into disruptive technologies for U.S. national security.


Proposal Due: 2021-09-08 2022-01-10 2022-09-08
Sponsor: U.S. Department of Health and Human Services
UG3 phase: $500,000 direct costs per year for 2 years; UJ3 phase: Not limited for 3 years

Funding Opportunity Number: PAR-21-183 Background Substance Use Disorders (SUDs) continue to have a significant adverse impact in the United States, resulting in more than $700 billion annually in health care expenditures, lost earnings, and expenses. The prevalence of SUD is widespread, with approximately 21.6 million individuals over the age of 12 experiencing substance use or dependence. There are safe and effective FDA approved medications for opioid and nicotine use disorders, but the long-term success rate is low. There are no FDA approved medications for other SUDs. Behavioral therapies for SUDs, delivered directly between a therapist and patient, have shown efficacy but the drug use relapse rates are high. New device and digital technologies are being investigated, and these interventions have only recently started achieving FDA authorization.


Proposal Due: 5/3/2021
Sponsor: U.S. Department of Defense
$1.8M total direct costs for single PI;
$2.1M total direct costs for Partnering PI Option for Early-Career investigator

Funding Opportunity Number: W81XWH-21-ARP-CTA The Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a major impact on the treatment or management of ASD. Applications are strongly encouraged to address one of the FY21 ARP Clinical Trial Award Areas of Interest . If the proposed study does not address an Area of Interest, an explanation of how the study addresses an important problem with respect to individuals with ASD must be provided. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), behavioral interventions, devices, clinical guidance, and/or emerging approaches and technologies. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A.


Proposal Due: 5/3/2021
Sponsor: U.S. Department of Defense
$550,000 total direct costs for up to 3 years

Funding Opportunity Number: W81XWH-21-ARP-IDA The Autism Research Program (ARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. Applications are strongly encouraged to address one of the FY21 ARP Idea Development Award Areas of Interest. If the proposed study does not address an Area of Interest, an explanation of how the study addresses an important problem with respect to individuals with ASD must be provided. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. Applications to the Fiscal Year 2021 (FY21) Autism Research Program (ARP) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S.


Proposal Due: 5/3/2021
Sponsor: U.S. Department of Defense
$550,000 total direct costs for up to 3 years

Funding Opportunity Number: W81XWH-21-ARP-CDA The FY21 Autism Research Program (ARP) Career Development Award supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, high-impact ideas or early-phase, proof-of-principle clinical trials with the potential to have a major impact on ASD. Applications are strongly encouraged to address one of the FY21 ARP Career Development Award Areas of Interest. If the proposed study does not address an Area of Interest, an explanation of how the study addresses an important problem with respect to individuals with ASD must be provided. Program Description Applications to the Fiscal Year 2021 (FY21) Autism Research Program (ARP) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S.


Proposal Due: 2021-05-05 2021-07-28
Sponsor: U.S. Department of Defense
$350,000 total direct costs for 2 years

Funding Opportunity Number: W81XWH-21-LCRP-IDA The FY21 LCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. Research applications in the area of mesothelioma will not be accepted. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. New Investigators: The FY21 LCRP Idea Development Award mechanism encourages applications from independent investigators in the early stages of their careers (i.e., within 10 years of their first faculty appointment or equivalent).


Proposal Due: 7/29/2021
Sponsor: U.S. Department of Defense
$1 million total direct costs for 4 years

Funding Opportunity Number: W81XWH-21-PRCRP-BHSA The Behavioral Health Science Award supports innovative research and high-reward studies that span the spectrum of behavioral health science, including quality of life, symptom management, resilience, neurocognitive deficits, and psychosocial issues related to cancer diagnosis, treatment, and survivorship. Studies must address one or more of these critical issues in at least one of the FY21 PRCRP Topic Areas .


Proposal Due: 5/26/2021
Sponsor: U.S. Department of Defense
$300,000 total direct costs for 3 years

Funding Opportunity Number: W81XWH-21-TBDRP-CDA The FY21 TBDRP CDA supports early-career investigators in their efforts to conduct impactful research with the mentorship of an experienced tick-borne diseases researcher (i.e., the mentor), thus providing an opportunity to obtain the funding, guidance, and experience necessary for productive, independent careers at the forefront of tick-borne diseases research. This award supports impactful research projects with an emphasis on discovery that may be translational in nature, but are not clinical trials. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI's research and career development. It should be clear that the proposed research is intellectually designed by the PI and not a product of the mentor.


Proposal Due: 5/26/2021
Sponsor: U.S. Department of Defense
$600,000 total direct costs for 3 years

Funding Opportunity Number: W81XWH-21-TBDRP-IDA The FY21 TBDRP IDA intends to support research that could lead to impactful discoveries or significant advancements that will accelerate progress toward improving Lyme disease and/or other tick-borne diseases research, patient care, and/or quality of life for military Service Members, Veterans, and their beneficiaries, as well as the American public. This research should be conceptually innovative, introducing a new concept or question, challenging existing paradigms, approaching issues from a new perspective, or exhibiting other uniquely creative qualities, and should not merely be an incremental advance upon published data. Applications must describe the short- and long-term impact of the proposed research, as well as the evidence-based burden of disease on public health.


Proposal Due: 1/12/2022
Sponsor: National Science Foundation
$1,700,000 total costs for a duration of four years

Funding Opportunity Number: NSF 21-527 Creating effective solutions to our most pressing environmental and sustainability challenges requires imaginative thinking - the kind that evolves when researchers from disparate fields, expertise, or perspectives fully immerse themselves in work toward a common goal. The National Academies of Sciences, Engineering and Medicine (NASEM), in their report "" Environmental Engineering for the 21 st Century: Addressing Grand Challenges ,"" identified five critical challenges we must address as a society: - Sustainably supply food, water, and energy - Curb climate change and adapt to its impacts - Design a future without pollution and waste - Create efficient, healthy, and resilient cities - Foster informed decisions and actions The report further states, ""The challenges provide focal points for evolving environmental engineering education, research, and practice toward increased contributions and a greater impact.


Proposal Due: 2021-03-10 2022-03-10
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-19-344 Background Despite the rapid growth and adoption of machine learning and artificial intelligence (AI) techniques to scientific questions, the lack of insight into the inner workings of these approaches has impeded full scientific understanding. For NIMH, the ultimate goal is a deep mechanistic understanding of normative brain functions and the pathophysiology of psychiatric disorders. However, machine learning techniques have often been applied to categorize and predict neural and behavioral outcomes without providing an understanding of what drives those predictions and classifications. Without knowing the factors critical to a machine-learning based outcome, it is difficult to optimize these approaches for novel conditions or to identify targets for further study or intervention development.


Proposal Due: 2021-03-16 2021-06-16 2021-07-16 2021-10-16 2021-11-16 2022-02-16 2022-03-16
Sponsor: NIH
$275,000 total direct costs for 2 years

Funding Opportunity Number: PAR-19-254 Support for Early-Stage Technology Development Is Critical to Advance Biomedical Research Biomedical research is enabled and accelerated by the development of advanced technologies. Technology enables science by providing new ways to answer questions, and more importantly, allowing new types of questions to be asked that could not be anticipated in the absence of the enabling technology. New knowledge drives the imperative for new tools, and those tools open new questions, in a mutually reinforcing positive feedback loop that drives science forward. A study by NIGMS staff in 2015, which included substantial, detailed input from the biomedical research community in response to a Request for Information ( NOT-GM-15-118 ), concluded that there is a significant unmet need for explicit support of early stage technology development, before nascent tools are ready to be applied to untested biomedical research problems.


Proposal Due: 3/15/2023
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-17-250 Background Secreted extracellular vesicles (EVs) play roles in many biological processes. In some cases these vesicles appear to travel through the body and fuse with specific cell types to deliver nucleic acid, protein or other cargoes that may alter cellular phenotypes. In the nervous system, EVs may function in neuronal-glial communication, synaptic plasticity, immune surveillance, or as endocannabinoid carriers. However the role of EVs in CNS disorders and SUDs is not well characterized. In addition, EVs from body fluids such as blood, cerebrospinal fluid, urine, saliva, semen, breast milk, and amniotic fluid could provide useful biomarkers for a variety of human diseases including CNS disorders. Understanding EV dynamics and cargoes across the trajectory of addiction may help to identify useful biomarkers for diagnosing: 1) drug use history (the type, quantity, and/or frequency of drug use), 2) the stage/trajectory of addiction (e.g.


Proposal Due: 3/15/2023
Sponsor: U.S. Department of Health and Human Services
$27500 total direct costs for 2 years

Funding Opportunity Number: PAR-17-242 Background Secreted extracellular vesicles (EVs) play roles in many biological processes. In some cases these vesicles appear to travel through the body and fuse with specific cell types to deliver nucleic acid, protein or other cargoes that may alter cellular phenotypes. In the nervous system, EVs may function in neuronal-glial communication, synaptic plasticity, immune surveillance, or as endocannabinoid carriers. However the role of EVs in CNS disorders and SUDs is not well characterized. In addition, EVs from body fluids such as blood, cerebrospinal fluid, urine, saliva, semen, breast milk, and amniotic fluid could provide useful biomarkers for a variety of human diseases including CNS disorders. Understanding EV dynamics and cargoes across the trajectory of addiction may help to identify useful biomarkers for diagnosing: 1) drug use history (the type, quantity, and/or frequency of drug use), 2) the stage/trajectory of addiction (e.g.


Proposal Due: 2021-06-05 2021-07-05 2021-10-05 2021-11-05 2022-02-05 2022-03-05
Sponsor: NIH
$500,000 direct costs per year for 4 years

Funding Opportunity Number: PAR-19-253 Support for Early-Stage Technology Development is Critical to Advance Biomedical Research Biomedical research is enabled and accelerated by the development of advanced technologies. Technology enables science by providing new ways to answer questions, and more importantly, allowing new types of questions to be asked that could not be anticipated in the absence of the enabling technology. New knowledge drives the imperative for new tools, and those tools open new questions, in a mutually reinforcing positive feedback loop that drives science forward. A study by NIGMS staff in 2015, which included substantial, detailed input from the biomedical research community in response to a Request for Information ( NOT-GM-15-118 ), concluded that there is a significant unmet need for explicit support of early stage technology development, before nascent tools are ready to be applied to untested biomedical research problems.


Proposal Due: 2021-06-16 2021-07-16
Sponsor: U.S. Department of Health and Human Services
$300,000 total costs for 2 years

Funding Opportunity Number: PA-17-246 Purpose This FOA issued by AHRQ invites grant applications for funding to conduct exploratory and developmental research grants (R21) for projects in the early and conceptual stages of development that will contribute to the evidence base of how health information technology (IT) improves health care quality and outcomes. Background AHRQ is interested in exploring how health IT can improve health care quality and outcomes by enabling more effective population health management and patient-centered care delivery and coordination. Health IT can enable these key functions of learning health systems by helping small and large health care providers effectively share information and apply available data and evidence to support care decisions and continuous improvement at both the individual and population levels.


Proposal Due: 6/1/2021
Sponsor: U.S. Department of Health and Human Services
$2 Million

Funding Opportunity Number: PAR-21-126 The purpose of this funding opportunity is to continue the High-End Instrumentation (HEI) Grant Program administered by the Office of Research Infrastructure Programs (ORIP). The objective of the Program is to make available to institutions high-end cutting-edge research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in basic, translational, and clinical biomedical or biobehavioral research. The HEI program provides funds to purchase or upgrade a single item of expensive, leading-edge, specialized, commercially available instrument or an integrated instrumentation system. An integrated instrumentation system is one in which the components, when used in conjunction with one another, perform a function that no single component can provide. The components must be dedicated to the system and not used independently.


Proposal Due: 6/14/2021
Sponsor: National Science Foundation
$250,000 total costs for 2 years

Funding Opportunity Number: NSF 21-570 With emphasis in helping to launch the careers of pre-tenure faculty in Mathematical and Physical Sciences (MPS) fields at minority-serving institutions (MSIs), predominantly undergraduate institutions (PUIs), and Carnegie Research 2 (R2) universities, and with the goal of achieving excellence through diversity, the Directorate for Mathematical and Physical Sciences hereby announces a call for Launching Early-Career Academic Pathways (LEAPS-MPS) proposals. This LEAPS-MPS call also aims to broaden participation to include members from groups underrepresented in the Mathematical and Physical Sciences, including Blacks and African Americans, Hispanics, Native Americans, Alaska Natives, and Native Hawaiians, and other Pacific Islanders. These grants are intended to support MPS principal investigators in initiating their research programs early in their careers, particularly at the aforementioned institutions.


Proposal Due: 6/1/2021
Sponsor: U.S. Department of Health and Human Services
$250,000

Funding Opportunity Number: PAR-21-125 With this Funding Opportunity Announcement, ORIP introduces the Basic Instrumentation Grant (BIG) Program. The Program targets institutions that have not received in any of the last 3 Federal fiscal years (FYs 2018-2020) a substantial S10 shared instrumentation award funding of a total of $250,001 or greater - see Section III.3 . Additional Information on Eligibility for eligibility requirements. Institutions that are not major recipients of NIH research funding are especially encouraged to apply. Often such institutions are in Institutional Development Award ( IDeA )-eligible states or serve underrepresented populations. The main objective of the BIG Program is to make available modern scientific instruments that are needed by NIH-funded investigators and other groups of biomedical scientists to advance their research and to broaden access to modern technologies at academic and research institutions nationwide.


Proposal Due: 2021-05-26 2022-05-26 2023-05-26
Sponsor: U.S. Department of Health and Human Services
Not Limited; 5 years

Funding Opportunity Number: PAR-21-147 The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In order to accomplish this goal, NRSA training programs are designed to train individuals to conduct research and to prepare for research careers. More information about NRSA programs may be found at the Ruth L. Kirschstein National Research Service Award (NRSA) website. Purpose and Background Information The NRSA program has been the primary means of supporting predoctoral and postdoctoral research training programs since enactment of the NRSA legislation in 1974.


Proposal Due: 2021-05-17 2022-01-18 2022-05-17
Sponsor: U.S. Department of Health and Human Services
$750,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-19-367 Purpose Supporting fundamental research by funding individual projects has a number of consequences that reduce the efficiency and effectiveness of the biomedical research enterprise in the U.S. To address these issues and increase the efficiency and efficacy of grant funding, the NIGMS Maximizing Investigators' Research Award (MIRA) is a single grant to provide support for the NIGMS-relevant program of research in an investigator's laboratory. For this FOA, the ""program of research"" is defined as a collection of projects in an investigator's lab that are within the mission of NIGMS .


Proposal Due: 2021-05-03 2022-02-22
Sponsor: National Aeronautics and Space Administration
National Science Foundation
U.S. Department of Agriculture
U.S. Department of Defense
U.S. Department of Energy
$250,000 to $1,500,000 in total costs for up to 4 years

Funding Opportunity Number: NSF 21-559 The National Robotics Initiative 3.0: Innovations in Integration of Robotics (NRI-3.0) program builds upon the preceding National Robotics Initiative (NRI) programs to support fundamental research in the United States that will advance the science of robot integration.The program supports research that promotes integration of robots to the benefit of humansincludinghuman safety and human independence. Collaboration between academic, industry, non-profit, and other organizations is encouraged to establish better linkages between fundamental science and engineering and technology development, deployment, and use. The NRI-3.0 program is supported by multiple agencies of the federal government including the National Science Foundation (NSF), the U.S.


Proposal Due: 3/12/2021
Sponsor: U.S. Department of Health and Human Services
Salary plus $50,000 (research development costs) per year for 5 years

Funding Opportunity Number: PAR-18-336 The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NIH Institutes and Centers (ICs) support a variety of mentored and non-mentored career development award programs designed to foster the transition of new investigators to research independence and to support established investigators in achieving specific objectives. Candidates should review the different career development (K) award programs, to determine the best program to support their goals. More information about Career programs may be found at the NIH Extramural Training Mechanisms website.


Proposal Due: 2021-03-16 2021-05-07 2021-06-16 2021-07-16 2021-09-07 2021-10-16 2021-11-16 2022-01-07 2022-02-16
Sponsor: U.S. Department of Health and Human Services
$400,000 direct costs for 3 years

Funding Opportunity Number: PAR-20-084 The rapid evolution and vitality of the biomedical sciences benefit from the contributions and creativity of investigators in the early stages of their careers, and a continuous infusion of new ideas, techniques, and perspectives from other fields. This Trailblazer Award is an opportunity for New and Early Stage Investigators to pursue research programs of interest to the NIBIB at the interface of engineering and/or the physical sciences with the biomedical sciences. Applicants are encouraged to contact the appropriate NIBIB Program Director assigned to their specific scientific program area ( https://www.nibib.nih.gov/research-funding ) to discuss the appropriateness of the project before submission.


Proposal Due: 4/14/2021
Sponsor: U.S. Department of Health and Human Services
Not limited; 5 years

Funding Opportunity Number: RFA-LM-21-001 Purpose The purpose of the National Library of Medicine (NLM) Institutional Training Program in Biomedical Informatics and Data Science is to support pre-doctoral and post-doctoral training for research careers in biomedical informatics and data science. Applications may be for the creation of entirely new training programs or for the renewal of existing NLM training program grants. NLM's training programs help meet the growing need for investigators trained in biomedical computing, data science and related information fields as they directly relate to application domains in health and biomedicine, including health care delivery, basic biomedical research, clinical and translational research, public health and similar areas. Biomedical informatics and data science training is, by its nature, interdisciplinary.


Proposal Due: 7/31/2022
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-MH-20-055 Purpose The purpose of this Notice of Special Interest (NOSI) is to encourage research focused on Black child and adolescent suicide. Recent data suggest that Black youth, especially those under age 13, appear to be at higher than average risk for suicide and suicide-related behaviors. Background Over the past several years, there has been a significant increase in the rate of suicide and suicide ideation and behaviors (SIB) among Black youth. From 2001 to 2015, an analysis found that Black youth under 13 were twice as likely to die by suicide compared to their White peers, and the suicide death rate among Black youth was found to be increasing faster than any other racial/ethnic group. In response to these trends, the Congressional Black Caucus convened an emergency Taskforce in 2019 to examine Black youth suicide and mental health.


Proposal Due: 5/9/2023
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-CA-20-045 Purpose The purpose of this Notice is to inform potential applicants of the special interest of the National Cancer Institute (NCI) in encouraging the submission of applications to either PAR-20-089 Biomedical Data Repository ( U24-Clinical Trial Not Allowed) or PAR-20-097 Biomedical Knowledgebase ( U24-Clinical Trial Not Allowed) FOAs, focused on the establishment of new, or continued development of established cancer data resources that use state-of-the-art and cost-effective technologies and approaches, and that are of high value to the broad cancer research community. This NOSI applies to applications for both data repositories and knowledgebases. Research Objectives For the purpose of this Notice, we use the term "" resource "" to encompass both data repositories and knowledgebases. Through this NOSI, NCI will support the development of resources that are clearly linked to broad use cases in cancer research.


Proposal Due: 1/8/2022
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-CA-20-031 Purpose The purpose of this Notice is to inform potential applicants of the special interest of the National Cancer Institute (NCI) in encouraging the submission of applications that advance early detection of head and neck cancer (HNC) to apply genomics, molecular signatures, and epidemiology in clinical studies for distinguishing benign from malignant lesions. This initiative encourages discovery and development of molecular markers to combine with currently available HNC detection methods to increase sensitivity and specificity. Background Head and Neck Cancer (HNC), the sixth leading cancer by incidence worldwide, is a heterogeneous group of malignancies that arise in the oral and nasal cavities, paranasal sinuses, pharynx, larynx, and salivary glands. In the United States, more than 65,000 individuals are diagnosed with HNC every year.


Proposal Due: 9/8/2023
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-DA-20-017 Purpose To encourage research project applications aimed at developing and/or implementing specialized software for tracking, characterization, and analysis of Substance Use Disorder (SUD)-related behaviors. Background NIDA's mission includes identification of both the biological and behavioral causes and consequences of SUD. While technology to monitor and analyze neural activity at increasingly high spatiotemporal resolution is rapidly progressing, the development of methods to track, characterize and analyze behavior has lagged behind. Indeed, a considerable amount of behavioral data is still ""hand-scored"" (i.e. subjectively categorized and tallied by human observers), a process which is time-consuming, lacks rigor and reproducibility, and is not well-suited for the identification of unanticipated behaviors or complex behavioral sequences/patterns.


Proposal Due: 9/5/2022
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-DK-20-036 Purpose The purpose of this Notice is to inform potential applicants to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of an area of special interest in research to improve methods to assess body composition in infants and young children ages birth through 5 years. Background Obesity in children continues to increase and remains a major public health problem with the prevalence among youth ages 2-19 years estimated to be 18%. Racial/ethnic disparities in prevalence remain significant with non- Hispanic Black and Hispanic youth having higher rates of obesity than non-Hispanic White children .


Proposal Due: 1/10/2022
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-DC-20-007 Purpose The purpose of this Notice of Special Interest (NOSI) is to improve health outcomes for individuals with deafness or communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. Background One of the missions of the NIDCD is to improve the health outcomes for individuals with deafness or communication disorders. Scientifically-validated prevention, treatment, and rehabilitation approaches will lead to better personal and public health only if they are translated effectively from the research laboratory into routine practice. Efficacy studies measure how well a treatment or intervention works in a clinical trial or laboratory setting.


Proposal Due: 5/8/2023
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-MH-20-013 Purpose The National Institute of Mental Health is issuing this Notice to highlight interest in receiving grant applications focused on understanding and addressing the impact of mental health comorbidities, including mental health disorders as well as violence and trauma, on the HIV prevention and treatment continua. In the U.S. and globally, mental disorders are prevalent among populations at risk for HIV acquisition and transmission, as well as people living with HIV (PLHIV). Exposure to violent or traumatic events is frequently comorbid with mental health disorders, and also impacts the HIV prevention and treatment continua. Mental disorders and violence/trauma are associated with increased HIV acquisition and transmission risk behaviors, and they may be a barrier to the uptake of HIV prevention tools such as HIV testing and Pre-Exposure Prophylaxis (PrEP), as well as HIV care and treatment.


Proposal Due: 3/18/2022
Sponsor: U.S. Department of Health and Human Services
$150,000 Direct Costs

Notice Number: NOT-CA-20-012 Purpose The National Cancer Institute (NCI) SBIR Development Center recognizes that early-stage proof of concept studies can evolve rapidly, necessitating supplementary experiments and/or follow-on experiments for accelerated progress to position promising projects for stronger SBIR Phase II applications and to generate interest from follow-on investors and strategic partners. To accelerate the development of promising technologies, the NCI announces the opportunity for current NCI-funded SBIR Phase I grantees ( R43 grant mechanism only ) to seek supplemental project funding via the Administrative Supplement mechanism. The funds from these Administrative Supplements are intended to support research activities that are aimed at: 1. Achieving next critical milestones in the technology development pathway to make the applicants more competitive for Phase II applications and/or for raising private-sector capital; and 2.


Proposal Due: 9/8/2022
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-DC-20-008 Purpose Coronavirus Disease 2019 (COVID-19) is a recently emerged human disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is a paucity of data on the impact of SARS-CoV-2 on the sensory and communicative functions within the scientific mission areas of NIDCD. NIDCD invites applications for research on COVID-19 in relation to NIDCD's scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL). Given the early stage of COVID-19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models.


Proposal Due: 9/8/2021
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-AI-20-051 Purpose NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in select scientific areas using the following funding mechanisms: - PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) - PA-19-272 - PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) - PA-19-270 - PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) This NOSI replaces NOT-AI-20-031 , which was expired following the release of two FOAs that provide an expedited funding mechanism for research on SARS-CoV-2 and COVID-19 using the R01 and R21 funding mechanisms.


Proposal Due: 5/8/2023
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Notice Number: NOT-MD-20-025 Purpose Purpose The purpose of this Notice of Special Interest is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities. Background Although scientific and technological advances have improved the health and well-being of the U.S. population overall, racial and ethnic minorities, socioeconomically disadvantaged, underserved rural and sexual and gender minority populations continue to experience a disproportionate share of many acute or chronic diseases and adverse health outcomes, including the burden related to the recent COVID-19 disease outbreaks caused by the novel coronavirus (SARS-CoV-2) pandemic, and/or other pandemics, epidemics (e.g., dengue fever, zika, chikungunya) or public health emergencies. Several characteristics make addressing health disparities an especially challenging problem.


Proposal Due: 2021-06-05 2024-05-07
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Notice Number: NOT-HL-21-008 Purpose Background and Purpose Individuals with Postural Orthostatic Tachycardia Syndrome (POTS) suffer from an excessive increase in heart rate (tachycardia) and other symptoms that worsen upon standing or sitting up, such as light-headedness, shortness of breath, chest pain, and palpitations. It is likely that POTS has multiple underlying mechanisms resulting in subtypes of POTS that need to be identified and characterized. There is evidence that POTS can arise from abnormalities in autonomic nervous system function, immune system function including autoimmunity, regulation of blood volume and blood flow, or a combination of these factors. Genetic factors probably also affect susceptibility to POTS. Many people with POTS report a preceding medical or life-changing event such as viral infection, concussion, surgery, pregnancy, or puberty.


Proposal Due: 9/7/2025
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Notice Number: NOT-HL-20-788 Purpose The purpose of this trans-NIH Notice of Special Interest (NOSI) is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Environmental Health Sciences (NIEHS) have special interest in applications aiming to investigate the impact of personal interventions to reduce exposure to particulate matter (PM) in air pollution on cardiovascular and pulmonary (cardiopulmonary) outcomes. This notice specifically encourages intervention studies or clinical trials that examine the efficacy of personal air pollution interventions to reduce the adverse cardiopulmonary effects of Particulate Matter (PM) Background Substantial evidence supports PM 2.5 as the fifth leading risk factor for global mortality, accounting for roughly 8.9 million deaths per year - 213,000 in North America alone.


Proposal Due: 2021-06-05 2024-05-07
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Notice Number: NOT-HD-20-032 Purpose The purpose of this Notice of Special Interest (NOSI) is to solicit applications to support multi-disciplinary scientific teams proposing research using systems science approaches to address persistent public health challenges. Systems science refers to multi-level methodologies addressing complex behavioral and social phenomena. This initiative encourages applications for both basic and applied research, including methodological and measurement development, with a focus on human behavioral and/or social science. This initiative also seeks to promote interdisciplinary collaboration among health researchers and experts in mathematical modelling. Background Systems science is an interdisciplinary field comprising methodological approaches that address dynamic connections between a system's structure and its behavior over time.


Proposal Due: 1/8/2024
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-DA-20-058 There is an urgent need for remotely delivered Substance Use Disorder (SUD) treatments to reduce patient burden and for methods to conduct clinical trials remotely. The purpose of this NOSI is to stimulate research to evaluate the safety and efficacy of telemedicine or remotely provided treatments for SUD, and to develop tools for remote collection of data in clinical trials of treatments for SUD. Background Most mainstream treatments for SUD currently rely on in-person clinical visits as an essential setting for treatment delivery and outcomes monitoring. The advent of the COVID-19 pandemic has substantially disrupted in-person treatment delivery, demonstrating the limitations of relying on in-person approaches. Further, even during normal circumstances, in-person treatment delivery results in additional travel-related demands and schedule conflicts (e.g., work, childcare) that can be burdensome to patients.


Proposal Due: 9/8/2022
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-MH-20-031 Purpose Risk identification is a key component of suicide prevention. In healthcare settings, current risk identification is typically obtained through patients' endorsement of items on screeners, either administered by a clinician or completed by patients through a tablet or via paper/pencil. Another way to identify people with suicide risk is via risk algorithms based on medical record data, which can be considered complementary to the traditional screening associated with clinical encounters in several ways: 1) it does not rely on people to answer questions, it looks at what they have done as opposed to what they say 2) you can look across a panel of people--not just those seen in face-to-face healthcare contacts. Risk algorithms have been shown in multiple settings to be a validated way to identify individuals with high suicide risk who warrant additional clinical attention.


Proposal Due: 11/13/2021
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-AG-20-017 Purpose This Notice of Special Interest (NOSI) is intended to promote research on the use of digital technology for early detection and monitoring of cognitive and functional decline in persons with Alzheimer's disease (AD) and AD-related dementias (ADRD). Background Early diagnosis and monitoring of AD/ADRD is an unmet need and a major goal in the Department of Health and Human Services National Plan to Address Alzheimers Disease. There is evidence that the functional, psychological, pathological, and physiological changes underlying AD/ADRD may emerge many years prior to the clinical manifestation of cognitive symptoms, prompting this call for earlier indicators of disease risk and subclinical disease burden. Current biomarkers for early detection of prodromal AD/ADRD (e.g., PET/MRI imaging) are costly and invasive.


Proposal Due: 9/5/2023
Sponsor: U.S. Department of Health and Human Services

Notice Number: NOT-AA-20-018 Purpose The purpose of this Notice of Special Interest (NOSI) is to solicit applications to support the secondary analyses of existing data sets with the goal of enhancing our understanding of the following: 1) the patterns and trajectories of alcohol consumption, 2) the epidemiology and etiology, including genetics, of alcohol-related problems and disorders, and 3) alcohol-related health services and health systems, including access, quality, and efficiency. This Notice encourages applications proposing innovative analyses of existing alcohol research data, answering novel research hypotheses and questions, and developing and testing advanced analytical methodologies applicable to alcohol related epidemiological, behavioral and genetics research.


Proposal Due: 7/1/2021
Sponsor: Paralyzed Veterans of America
$150,000 total costs

From transplanting cells and regenerating damaged nerve fibers to designing adaptive canoe seats, the Paralyzed Veterans of America Research Foundation supports innovative research and fellowships that improve the lives of those with spinal cord injury and disease (SCI/D). The Research Foundation, a 501(c)(3) nonprofit, last year funded $796,402 in grants, and since its inception in 1976 it has funded $51,315,123.


Proposal Due: 2021-07-14 2022-01-12
Sponsor: National Science Foundation
PFI-TT projects: $250,000 total costs for 18-24 months; . PFI-RP projects: $550,000 total costs for 36 months.

Funding Opportunity Number: NSF 19-506 The Partnerships for Innovation (PFI) Program within the Division of Industrial Innovation and Partnerships (IIP) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit. PFI has five broad goals, as set forth by the American Innovation and Competitiveness Act of 2017 (the Act, S.3084 114th Congress; Sec. 602.


Proposal Due: 6/15/2021
Sponsor: NIH
$250,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-19-246 The NIH Research Education Program (R25) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers. The over-arching goals of the NIH R25 program are to: (1) complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs; (2) encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research; (3) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences; and (4) foster a better understanding of biomedical, behavioral and clinical research and its implications.


Proposal Due: 2021-04-23 2021-07-19 2021-10-22
Sponsor: RADx-UP
$200,000 in direct costs for a 12- month period

Duke University in partnership with the University of North Carolina, Chapel Hill, is serving as the Coordination and Data Collection Center (CDCC) for the National Institutes of Health (NIH)-supported Rapid Acceleration of Diagnostics- Underserved Populations (RADx-UP) program. The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in communities of underserved and vulnerable populations. The purpose of the overall program is to better understand factors that have led to the disproportionate impact of COVID-19 on these groups, and develop interventions to reduce those disparities. For the purpose of this RFA, populations that are underserved as well as populations that are COVID-19 vulnerable due to medical, geographic, and social factors, are defined below: Underserved: NIH-designated health disparity populations known to experience barriers to accessing health coverage and basic health care services as well as disparities from COVID-19.


Proposal Due: 2021-05-07 2021-06-25 2021-09-07 2021-10-25 2022-01-07
Sponsor: U.S. Department of Health and Human Services
$300,000

Funding Opportunity Number: PAR-19-134 The National Institutes of Health (NIH) is continuing to make a special effort to stimulate research at educational institutions that provide baccalaureate and/or advanced degrees for a significant number of the Nation's research institutions that have not been major recipients of NIH support. Since Fiscal Year (FY) 1985 Congressional appropriations for the NIH have included funds for this initiative, known as the Academic Research Enhancement Award (AREA) program that was intended to focus on undergraduate institutions ( PAR-18-714 ). To complement the AREA program, this funding opportunity announcement (FOA) specifically supports eligible health professional schools and graduate schools to provide research experiences to undergraduate and/or graduate students pursuing biomedical or behavioral research.


Proposal Due: 2021-05-07 2021-06-25 2021-09-07 2021-10-25 2022-01-07
Sponsor: U.S. Department of Health and Human Services
$300,000 total direct costs for 3 years

The National Institutes of Health (NIH) is continuing to make a special effort to stimulate research at educational institutions that provide baccalaureate and/or advanced degrees for a significant number of the Nation's research institutions that have not been major recipients of NIH support. Since Fiscal Year (FY) 1985 Congressional appropriations for the NIH have included funds for this initiative, known as the Academic Research Enhancement Award (AREA) program that was intended to focus on undergraduate institutions (PAR-18-714). To complement the AREA program, this funding opportunity announcement (FOA) specifically supports eligible health professional schools and graduate schools, to provide research experiences to undergraduates and graduate students pursuing biomedical or behavioral research.


Proposal Due: 2021-05-07 2021-05-25 2021-09-07 2021-09-25 2022-01-07 2022-01-25 2022-05-07 2022-05-25 2022-09-07
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Funding Opportunity Number: PA-20-162 The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In order to accomplish this goal, NRSA training programs are designed to train individuals to conduct research and to prepare for research careers. More information about NRSA programs may be found at the Ruth L. Kirschstein National Research Service Award (NRSA) website. Purpose and Background Information The NRSA program has been the primary means of supporting predoctoral and postdoctoral research training programs since enactment of the NRSA legislation in 1974. Research training activities can be in basic biomedical or clinical sciences, in behavioral or social sciences, in health services research, or in any other discipline relevant to the NIH mission.


Proposal Due: 9/15/2021
Sponsor: Scleroderma Foundation
$150,000 total costs for 3 years

Purpose: The Scleroderma Foundation seeks applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to scleroderma. This grant supports promising research that is likely to lead to individual research project grants.


Proposal Due: 6/1/2021
Sponsor: U.S. Department of Health and Human Services
$600,000

Funding Opportunity Number: PAR-21-127 The purpose of this funding opportunity is to continue the Shared Instrumentation Grant (SIG) Program administered by ORIP. The objective of the Program is to make available to institutions high-priced research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in basic, translational, or clinical biomedical and bio-behavioral research. The SIG Program provides funds to purchase or upgrade a single item of expensive, state-of-the-art, specialized, commercially available instrument or an integrated instrumentation system. An integrated instrumentation system is one in which the components, when used in conjunction with one another, perform a function that no single component can provide. The components must be dedicated to the system and not used independently.


Proposal Due: 2021-05-26 2022-05-26
Sponsor: U.S. Department of Health and Human Services
$100,000 direct costs per year for 4 years

Funding Opportunity Number: PAR-21-169 The National Institutes of Health (NIH) recognizes that scientists and students from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. Benefits of a diverse scientific workforce include fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved populations participate in, and benefit from health research, and enhancing public trust. Yet many institutions that enroll significant numbers of students from groups underrepresented in science are under-resourced and their faculty receive fewer NIH research grants ( Hoppe 2019 ). There is a pressing need to enhance biomedical research capacity and opportunities for student research at these institutions.


Proposal Due: 2021-09-28 2022-09-28
Sponsor: U.S. Department of Health and Human Services
$125,000 direct costs per year for 4 years

Funding Opportunity Number: PAR-21-173 The National Institutes of Health (NIH) recognizes that scientists and students from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. Benefits of a diverse scientific workforce include fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved populations participate in, and benefit from research, and enhancing public trust. Yet many institutions that enroll significant numbers of students from groups underrepresented in science are under-resourced and their faculty receive fewer NIH research grants ( Hoppe 2019 ). There is a pressing need to enhance biomedical research capacity and opportunities for student research at these institutions.


Proposal Due: 5/7/2021
Sponsor: U.S. Department of Health and Human Services
$100,000 direct costs per year for 3 years
NTID faculty only

Funding Opportunity Number: PAR-20-040 Purpose and Background Information The National Institutes of Health (NIH) recognizes the need to diversify the scientific workforce by enhancing the participation of individuals from groups identified as underrepresented in the biomedical, clinical, behavioral and social sciences (collectively termed ""biomedical"") research workforce. Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogenous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual interests to address complex scientific problems.


Proposal Due: 5/7/2021
Sponsor: U.S. Department of Health and Human Services
$250,000 direct costs per year for 4 years
NTID faculty only

Funding Opportunity Number: PAR-20-039 Purpose and Background Information The National Institutes of Health (NIH) recognizes the need to diversify the scientific workforce by enhancing the participation of individuals from groups identified as underrepresented in the biomedical, clinical, behavioral and social sciences (collectively termed ""biomedical"") research workforce. Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogenous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual interests to address complex scientific problems.


Proposal Due: 5/21/2021
Sponsor: U.S. Department of Health and Human Services
$500,000 direct costs per year for 5 years

Funding Opportunity Number: PAR-19-218 The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In order to accomplish this goal, NRSA training programs are designed to train individuals to conduct research and to prepare for research careers. More information about NRSA programs may be found at the Ruth L. Kirschstein National Research Service Award (NRSA) website.


Proposal Due: 2021-06-16 2021-07-16 2021-10-16
Sponsor: U.S. Department of Health and Human Services
R21 phase: $27,500 total direct costs for 2 years;
R33 phase: $750,000 total direct costs for 3 years

Funding Opportunity Number: PA-21-164 Purpose This Funding Opportunity Announcement (FOA) invites applications for research projects that test promising digital healthcare interventions aimed at improving the quality of healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. Transition to the R33 phase is not guaranteed for all grants awarded under this FOA. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds.